Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,559,000 | 2,704,000 | 2,302,000 | 1,342,000 | 2,779,000 |
| Marketable Securities | 13,680,000 | 10,727,000 | 9,119,000 | 18,650,000 | 14,146,000 |
| Receivables | 10,024,000 | 9,873,000 | 9,452,000 | 8,221,000 | 10,002,000 |
| Inventories | 8,184,000 | 8,074,000 | 8,148,000 | 7,578,000 | 7,925,000 |
| Income taxes - deferred | 3,686,000 | 3,582,000 | 3,624,000 | N/A | 3,263,000 |
| Other current assets | 2,450,000 | 2,343,000 | 2,190,000 | 5,350,000 | 2,176,000 |
| TOTAL | $41,583,000 | $37,303,000 | $34,835,000 | $41,141,000 | $40,291,000 |
| Non-Current Assets | |||||
| PPE Net | 14,036,000 | 13,919,000 | 13,971,000 | 13,865,000 | 13,505,000 |
| Investments And Advances | 6,444,000 | 6,595,000 | 6,945,000 | 7,015,000 | 7,311,000 |
| Intangibles | 100,920,000 | 102,420,000 | 104,083,000 | 104,693,000 | 105,799,000 |
| Other Non-Current Assets | 4,855,000 | 4,744,000 | 4,779,000 | 5,082,000 | 5,246,000 |
| TOTAL | $126,255,000 | $127,678,000 | $129,778,000 | $130,655,000 | $131,861,000 |
| Total Assets | $167,838,000 | $164,980,000 | $164,612,000 | $171,797,000 | $172,151,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,385,000 | 11,583,000 | 9,010,000 | 9,953,000 | 9,448,000 |
| Accounts payable and accrued liabilities | 4,297,000 | 4,196,000 | 3,879,000 | 4,656,000 | 3,480,000 |
| Accrued Expenses | 2,096,000 | 1,791,000 | 1,911,000 | 2,196,000 | 1,932,000 |
| Other current liabilities | 10,490,000 | 10,125,000 | 10,950,000 | 11,115,000 | 10,446,000 |
| TOTAL | $29,013,000 | $32,156,000 | $27,365,000 | $30,427,000 | $28,217,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 33,652,000 | 28,935,000 | 31,831,000 | 33,538,000 | 34,503,000 |
| aiOther Non-Current Liabilities | 27,989,000 | 28,016,000 | 28,899,000 | 32,261,000 | 17,892,000 |
| TOTAL | $67,161,000 | $62,701,000 | $66,706,000 | $69,714,000 | $82,824,000 |
| Total Liabilities | $96,174,000 | $94,856,000 | $94,071,000 | $100,141,000 | $111,041,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,780,474 | 5,862,110 | 5,849,571 | 5,952,865 | 5,960,707 |
| Common Shares | 466,000 | 465,000 | 465,000 | 464,000 | 463,000 |
| Retained earnings | 91,995,000 | 89,860,000 | 89,961,000 | 85,291,000 | 75,043,000 |
| Other shareholders' equity | -10,051,000 | -9,636,000 | -9,024,000 | -8,952,000 | -8,802,000 |
| TOTAL | $71,664,000 | $70,124,000 | $70,541,000 | $71,656,000 | $61,110,000 |
| Total Liabilities And Equity | $167,838,000 | $164,980,000 | $164,612,000 | $171,797,000 | $172,151,000 |